Home
Conditions
Corynebacterium Infections

Clinical trial condition

Corynebacterium Infections

Explore clinical trials studying Corynebacterium Infections. Study availability and eligibility vary by location and protocol.

236 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Corynebacterium Infections trial results

Completed

Tdap Vaccine in Post-Partum Women

NCT01711645

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +12 more
Locations: Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center Nashville, Tennessee, United States

View Trial Details

Completed

DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants

NCT02094833

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +36 more
Locations: Daejeon, South Korea

Gyeonggi-do, South Korea

Gyeonggi-do, South Korea

Gyeongsangnam Do, South Korea

View all 16 locations

View Trial Details

Completed

Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)

NCT00337428

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +26 more
Locations: Not specified

View Trial Details

Completed

Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age

NCT00376779

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations: GSK Investigational Site Jarvenpaa, Finland

GSK Investigational Site Oulu, Finland

GSK Investigational Site Pori, Finland

GSK Investigational Site Tampere, Finland

View Trial Details

Completed

Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine

NCT00452686

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations: GSK Investigational Site Suining, China

View Trial Details

Completed

Study to Assess the Safety & Reactogenicity of GSK Biologicals' dTpa Vaccine (Boostrix) When Given at 6-8 Years of Age.

NCT00406562

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations: GSK Investigational Site Suining, China

View Trial Details

Completed

Study to Assess the Safety & Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of Age

NCT00379977

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +11 more
Locations: GSK Investigational Site Nanning, Guangxi, China

View Trial Details

Completed

Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants

NCT00320463

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +28 more
Locations: GSK Investigational Site Murmansk, Russia

GSK Investigational Site Perm, Russia

GSK Investigational Site Syktyvkar, Russia

GSK Investigational Site Syktyvkar, Russia

View Trial Details

Completed

Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants

NCT00197275

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +25 more
Locations: GSK Investigational Site Bangkok, Thailand

GSK Investigational Site Khon Kaen, Thailand

GSK Investigational Site Songkhla, Thailand

View Trial Details

Completed

Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules

NCT00316147

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +36 more
Locations: GSK Investigational Site Bangalore, India

GSK Investigational Site Baroda, India

GSK Investigational Site Goā, India

GSK Investigational Site New Delhi, India

View Trial Details

Corynebacterium Infections

Corynebacterium Infections trial results

Related conditions